Vitamin C-500 Complex - Vegetarian 100 Tablets
Item#: 0660
Manufacturer SKU: 733739006608
- With Bioflavonoids, Acerola & Rose Hips
- Vegetarian Formula
Vitamin C is perhaps the most popular vitamin known to man. It is consumed in a supplemental form by millions of people across the world for its antioxidant properties, which are well-documented in medical research. C-500 provides a potent dosage of this key vitamin and is blended with Bioflavonoids, Acerola, Rose Hips and Rutin, which are natural synergists to Vitamin C.*
From the FDA's website: "Some scientific evidence suggests that consumption of antioxidant vitamins may reduce the risk of certain forms of cancer. However, FDA has determined that this evidence is limited and not conclusive."
Suggested Usage
As a dietary supplement, take 1 tablet 1 or more times daily, preferably with meals.
Consider taking these other NOW® products:Related Links
| Serving Size: | 1 Tablet | ||
|---|---|---|---|
| Servings Per Container: | 100 | ||
| Amount Per Serving | % Daily Value* | ||
|
* Percent Daily Values are based on 2,000 calorie diet. † Daily Value not established. |
|||
| Vitamin C (as Ascorbic Acid) | 500 mg | 830% | |
| Citrus Bioflavonoids (37% total bioflavonoids as Hesperidin) | 100 mg | † | |
| Acerola Powder | 100 mg | † | |
| Rose Hips Powder (Rosae canina) (Fruit) | 100 mg | † | |
| Rutin Powder | 10 mg | † | |
Other Ingredients: Dicalcium Phosphate, Stearic Acid (vegetable source), Magnesium Stearate (vegetable source), Cellulose and Vegetable Coating.
Contains no: sugar, salt, starch, yeast, wheat, gluten, soy, milk, egg, shellfish or preservatives. Vegetarian/Vegan Product.
Caution: Do Not Eat Freshness Packet. Keep in Bottle.
Natural color variations may occur in this product.
Store in a cool, dry place. Please Recycle.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
This information current as of 5/10/13 2:18 PM.



Alpha Lipoic Acid





E-Newsletter sign-up
Facebook
Twitter